Coherus Oncology, Inc.CHRS
CHRS on Nasdaq: biological products, (no diagnostic substances).
Coherus Oncology, Inc. — ticker CHRS — is a healthcare company listed on Nasdaq operating in biological products, (no diagnostic substances).
Detailed business segments for Coherus Oncology, Inc. aren't currently in our reference dataset.
CHRS on the desk: alerts, trims, and member tracking.
CHRS hasn't shown up in Sensei's alert feed yet. When it sets up cleanly on the chart, members get the call in real time — entry, target, stop, and reasoning.
Full details unlock inside the app
Common questions about this stock.
What is CHRS?
CHRS is the trading symbol for Coherus Oncology, Inc., listed on Nasdaq in the healthcare sector.
What sector is CHRS in?
Coherus Oncology, Inc. (CHRS) is classified in the healthcare sector — specifically biological products, (no diagnostic substances), based on its SEC SIC classification.
Does Sensei trade CHRS?
When CHRS sets up cleanly on the chart, it shows up in the Sensei alert feed with entry, target, and stop levels. Members see every call in real time.
Where does CHRS trade?
CHRS trades on Nasdaq.
Is CHRS a stock or an ETF?
CHRS is a publicly-traded common stock, not an ETF.
Trade CHRS alongside Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.